Lv21
128 积分 2024-03-18 加入
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
4小时前
待确认
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
4小时前
已完结
Engineering sonogenetic EchoBack-CAR T cells
2个月前
已完结
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2个月前
已完结
Noncoding regions are the main source of targetable tumor-specific antigens
3个月前
已完结
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
4个月前
已完结
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
4个月前
已完结
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
5个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
5个月前
已完结
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
6个月前
已完结
皖公网安备34019202002308
